AKASTOR ASA (AKAST.OL) Fundamental Analysis & Valuation

OSL:AKASTNO0010215684

Current stock price

15.6 NOK
+0.22 (+1.43%)
Last:

This AKAST.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AKAST.OL Profitability Analysis

1.1 Basic Checks

  • AKAST had negative earnings in the past year.
  • In the past year AKAST had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: AKAST reported negative net income in multiple years.
  • In multiple years AKAST reported negative operating cash flow during the last 5 years.
AKAST.OL Yearly Net Income VS EBIT VS OCF VS FCFAKAST.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B

1.2 Ratios

  • The Return On Assets of AKAST (-2.46%) is worse than 80.00% of its industry peers.
  • With a Return On Equity value of -2.77%, AKAST is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.46%
ROE -2.77%
ROIC N/A
ROA(3y)5.94%
ROA(5y)5.3%
ROE(3y)6.26%
ROE(5y)6.89%
ROIC(3y)N/A
ROIC(5y)N/A
AKAST.OL Yearly ROA, ROE, ROICAKAST.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

1.3 Margins

  • The Gross Margin of AKAST (31.46%) is comparable to the rest of the industry.
  • AKAST's Gross Margin has declined in the last couple of years.
  • AKAST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.67%
GM growth 5Y-7.02%
AKAST.OL Yearly Profit, Operating, Gross MarginsAKAST.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400

4

2. AKAST.OL Health Analysis

2.1 Basic Checks

  • AKAST does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AKAST has about the same amout of shares outstanding than it did 1 year ago.
  • AKAST has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for AKAST has been reduced compared to a year ago.
AKAST.OL Yearly Shares OutstandingAKAST.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
AKAST.OL Yearly Total Debt VS Total AssetsAKAST.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • AKAST has a debt to FCF ratio of 8.35. This is a slightly negative value and a sign of low solvency as AKAST would need 8.35 years to pay back of all of its debts.
  • AKAST's Debt to FCF ratio of 8.35 is on the low side compared to the rest of the industry. AKAST is outperformed by 65.71% of its industry peers.
  • A Debt/Equity ratio of 0.04 indicates that AKAST is not too dependend on debt financing.
  • The Debt to Equity ratio of AKAST (0.04) is better than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 8.35
Altman-Z N/A
ROIC/WACCN/A
WACC10.37%
AKAST.OL Yearly LT Debt VS Equity VS FCFAKAST.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

2.3 Liquidity

  • A Current Ratio of 2.28 indicates that AKAST has no problem at all paying its short term obligations.
  • AKAST's Current ratio of 2.28 is fine compared to the rest of the industry. AKAST outperforms 74.29% of its industry peers.
  • AKAST has a Quick Ratio of 2.25. This indicates that AKAST is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 2.25, AKAST is doing good in the industry, outperforming 77.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 2.25
AKAST.OL Yearly Current Assets VS Current LiabilitesAKAST.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1

3. AKAST.OL Growth Analysis

3.1 Past

  • The earnings per share for AKAST have decreased strongly by -129.91% in the last year.
  • The Revenue for AKAST has decreased by -57.59% in the past year. This is quite bad
  • Measured over the past years, AKAST shows a very negative growth in Revenue. The Revenue has been decreasing by -40.53% on average per year.
EPS 1Y (TTM)-129.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
Revenue 1Y (TTM)-57.59%
Revenue growth 3Y-63.2%
Revenue growth 5Y-40.53%
Sales Q2Q%17.78%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.22% on average over the next years. This is quite good.
  • Based on estimates for the next years, AKAST will show a very negative growth in Revenue. The Revenue will decrease by -18.49% on average per year.
EPS Next Y56.83%
EPS Next 2Y103.3%
EPS Next 3Y18.52%
EPS Next 5Y15.22%
Revenue Next Year-76.76%
Revenue Next 2Y-6.52%
Revenue Next 3Y-27.51%
Revenue Next 5Y-18.49%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AKAST.OL Yearly Revenue VS EstimatesAKAST.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
AKAST.OL Yearly EPS VS EstimatesAKAST.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 -4

4

4. AKAST.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • AKAST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 7.21, which indicates a rather cheap valuation of AKAST.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AKAST indicates a rather cheap valuation: AKAST is cheaper than 88.57% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.36. AKAST is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 7.21
AKAST.OL Price Earnings VS Forward Price EarningsAKAST.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

  • AKAST's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AKAST is more expensive than 74.29% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, AKAST is valued a bit more expensive than the industry average as 74.29% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 125.72
EV/EBITDA 96.67
AKAST.OL Per share dataAKAST.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AKAST's earnings are expected to grow with 18.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y103.3%
EPS Next 3Y18.52%

0

5. AKAST.OL Dividend Analysis

5.1 Amount

  • No dividends for AKAST!.
Industry RankSector Rank
Dividend Yield 0%

AKAST.OL Fundamentals: All Metrics, Ratios and Statistics

AKASTOR ASA

OSL:AKAST (4/30/2026, 7:00:00 PM)

15.6

+0.22 (+1.43%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)02-12
Earnings (Next)05-13
Inst Owners2.71%
Inst Owner ChangeN/A
Ins Owners2.52%
Ins Owner ChangeN/A
Market Cap4.27B
Revenue(TTM)391.00M
Net Income(TTM)-148.00M
Analysts85.45
Price Target19.89 (27.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.75
Dividend Growth(5Y)N/A
DP-137.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)16.9%
Min Revenue beat(2)-6.44%
Max Revenue beat(2)40.24%
Revenue beat(4)1
Avg Revenue beat(4)3.64%
Min Revenue beat(4)-13.82%
Max Revenue beat(4)40.24%
Revenue beat(8)4
Avg Revenue beat(8)0.56%
Revenue beat(12)5
Avg Revenue beat(12)-6.66%
Revenue beat(16)8
Avg Revenue beat(16)-7.85%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)77.25%
Revenue NY rev (3m)63.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.21
P/S 10.93
P/FCF 125.72
P/OCF 99.4
P/B 0.8
P/tB 0.8
EV/EBITDA 96.67
EPS(TTM)-1.01
EYN/A
EPS(NY)2.16
Fwd EY13.87%
FCF(TTM)0.12
FCFY0.8%
OCF(TTM)0.16
OCFY1.01%
SpS1.43
BVpS19.47
TBVpS19.47
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -2.46%
ROE -2.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.46%
FCFM 8.7%
ROA(3y)5.94%
ROA(5y)5.3%
ROE(3y)6.26%
ROE(5y)6.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.67%
GM growth 5Y-7.02%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 8.35
Debt/EBITDA 5.29
Cap/Depr 15.79%
Cap/Sales 2.3%
Interest Coverage N/A
Cash Conversion 104.88%
Profit Quality N/A
Current Ratio 2.28
Quick Ratio 2.25
Altman-Z N/A
F-Score4
WACC10.37%
ROIC/WACCN/A
Cap/Depr(3y)202.35%
Cap/Depr(5y)135.2%
Cap/Sales(3y)19.4%
Cap/Sales(5y)15.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-129.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
EPS Next Y56.83%
EPS Next 2Y103.3%
EPS Next 3Y18.52%
EPS Next 5Y15.22%
Revenue 1Y (TTM)-57.59%
Revenue growth 3Y-63.2%
Revenue growth 5Y-40.53%
Sales Q2Q%17.78%
Revenue Next Year-76.76%
Revenue Next 2Y-6.52%
Revenue Next 3Y-27.51%
Revenue Next 5Y-18.49%
EBIT growth 1Y-102.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year311.77%
EBIT Next 3Y47.9%
EBIT Next 5YN/A
FCF growth 1Y-97.91%
FCF growth 3YN/A
FCF growth 5Y-25.08%
OCF growth 1Y-97.58%
OCF growth 3YN/A
OCF growth 5Y-27.25%

AKASTOR ASA / AKAST.OL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AKASTOR ASA?

ChartMill assigns a fundamental rating of 2 / 10 to AKAST.OL.


What is the valuation status of AKASTOR ASA (AKAST.OL) stock?

ChartMill assigns a valuation rating of 4 / 10 to AKASTOR ASA (AKAST.OL). This can be considered as Fairly Valued.


How profitable is AKASTOR ASA (AKAST.OL) stock?

AKASTOR ASA (AKAST.OL) has a profitability rating of 1 / 10.


Can you provide the financial health for AKAST stock?

The financial health rating of AKASTOR ASA (AKAST.OL) is 4 / 10.


What is the expected EPS growth for AKASTOR ASA (AKAST.OL) stock?

The Earnings per Share (EPS) of AKASTOR ASA (AKAST.OL) is expected to grow by 56.83% in the next year.